Chris Lewis

Chris Lewis has extensive experience in the biopharmaceutical industry, with a focus on quality control and microbiology. Chris has held various roles throughout their career, starting as a Quality Control Microbiology Manager at Amgen from 2005 to 2015. Chris then worked at Sandoz as an Associate Director of Quality Control from 2015 to 2016, followed by a position at AstraZeneca as a Senior Manager of Quality Control Microbiology from 2016 to 2019. Chris then joined AveXis, Inc. as an Associate Director of Quality Control from 2019 to 2020. Chris subsequently worked at Novartis Gene Therapies as the Director of Quality Control from 2020 to 2021. Currently, Chris holds the position of Senior Director and Head of Quality Control at Umoja Biopharma since July 2021.

Chris Lewis attended the University of Colorado Boulder, but no specific information about the degree obtained or field of study is provided.